Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
22 hedge funds and large institutions have $18.4M invested in Singular Genomics Systems, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
207% more capital invested
Capital invested by funds: $6M → $18.4M (+$12.4M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
8% less funds holding
Funds holding: 24 → 22 (-2)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.31M |
| 2 |
CL
CRCM LP
San Francisco,
California
|
+$898K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$693K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.6K |
| 5 |
JP Morgan Chase
New York
|
+$1.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$373K |
| 2 |
PA
Perceptive Advisors
New York
|
-$178K |
| 3 |
O
OrbiMed
New York
|
-$152K |
| 4 |
BlackRock
New York
|
-$41.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$186 | -22 | Closed |
|
OMIC Hedge Fund Activity: Q3 2024 in Review
22 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q3 2024, worth a combined $18.4M — up 207% from $6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of OMIC and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $3.31M. The largest seller was Casdin Capital, exiting entirely with an estimated $373K sold.
- 22 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q3 2024, down from 24 in Q2 2024.
- Funds reported $18.4M of Singular Genomics Systems, Inc. Common Stock stock for Q3 2024, up 207% quarter-over-quarter.
- 3 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q3 2024 and 5 closed out, a net change of -2 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q3 2024 was Tang Capital Management, an estimated $3.31M added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q3 2024 was Casdin Capital, an estimated $373K sold.
Based on aggregated 13F filings for Q3 2024.